Monocarboxylate transporter mediates uptake of lovastatin acid in rat cultured mesangial cells

Journal of Pharmaceutical Sciences

Volumn 91, Issue 12, 2002, Pages 2605-2613

  Nagasawa, Kazuki ^a   Nagai, Katsuhito ^a   Sumitani, Yuji ^a   Moriya, Yuka ^a   Muraki, Yuichi ^a   Takara, Kohji ^a   Ohnishi, Noriaki ^a   Yokoyama, Teruyoshi ^a   Fujimoto, Sadaki ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Lovastatin acid; Mesangial cell; Monocarboxylate transporter; Uptake

Indexed keywords

ADENOSINE TRIPHOSPHATE; LACTIC ACID; MEVINOLIN; MONOCARBOXYLATE TRANSPORTER; MONOCARBOXYLATE TRANSPORTER 1; MONOCARBOXYLATE TRANSPORTER 2; MONOCARBOXYLATE TRANSPORTER 4; TAQ POLYMERASE; UNCLASSIFIED DRUG; VALPROIC ACID; ISOPROTEIN; MESSENGER RNA;

ANIMAL CELL; CELL CULTURE; CELL PH; CELL TRANSPORT; CONFERENCE PAPER; CONTROLLED STUDY; DRUG UPTAKE; MESANGIUM CELL; MICHAELIS CONSTANT; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; ARTICLE; BIOSYNTHESIS; CYTOLOGY; GENETICS; MALE; MESANGIUM; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; CELLS, CULTURED; GLOMERULAR MESANGIUM; LOVASTATIN; MALE; MONOCARBOXYLIC ACID TRANSPORTERS; PROTEIN ISOFORMS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 0036893257     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.10246     Document Type: Conference Paper

References (31)

1. Mené P, Simonson MS, Dunn MJ. 1989. Physiology of the mesangial cell. Physiol Rev 69:1347-1424.
2. Striker JJ, Peten EP, Elliot SJ, Doi T, Striker GE. 1991. Biology of disease, mesangial cell turnover. Effect of heparin and peptide growth factor. Lab Invest 64:446-456.
3. Lovett DH, Sterzel RB. 1986. Cell culture approaches to the analysis of glomerular inflammation. Kidney Int 30:246-254.
4. Nagasawa K, Muraki Y, Matsuda T, Ohnishi N, Yokoyama T. 2000. Inhibitory effect of statins on fetal bovine serum-induced proliferation of rat cultured mesangial cells and correlation between their inhibitory effect and transport characteristics. J Pharm Sci 89:1594-1604.
5. --independent multispecific anion transporter mediates active transport of pravastatin into rat liver. Am J Physiol 264:G36-G44.
6. Tokui T, Nakai D, Nakagomi R, Yawa H, Abe T, Sugiyama Y. 1999. Pravastatin, an HMG-CoA reductase inhibitor, is transported by rat organic anion transporting polypeptide, oatp2. Pharm Res 16:904-908.
7. Tamai I, Tsuji A. 1996. Carrier-mediated approaches for drug delivery. Adv Drug Deliv Rev 20:5-32.
8. Tsuji A, Tamai I. 1996. Carrier-mediated intestinal transport of drugs. Pharm Res 13:963-977.
9. Tamai I, Tsuji A. 2000. Transporter-mediated permeation of drugs across the blood-brain barrier. J Pharm Sci 89:1371-1388.
10. Abe T, Kakyo M, Sakagami H, Tokui P, Nishio T, Tanemoto M, Nomura H, Hebert SC, Matsuno S, Kondo H, Yawo H. 1998. Molecular characterization and tissue distribution of a new organic anion transporter subtype (oatp3) that transports thyroid hormones and taurocholate and comparison with oatp2. J Biol Chem 273:22395-22401.
11. Tsuji A, Saheki A, Tamai I, Terasaki T. 1993. Transport mechanism of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors at the bloodbrain barrier. J Pharmacol Exp Ther 267:1085-1090.
12. Nomiyama M, Ohnishi N, Nagasawa K, Yokoyama T. 1998. Ticlopidine inhibits activation of mitogenactivated protein kinase by platelet-derived growth factor in cultured rat renal mesangial cells. Clin Exp Nephrol 2:117-123.
13. Kikkawa R, Umehara K, Haneda M, Arimura T, Ebata K, Shigeta Y. 1987. Evidence for existence of polyol pathway in cultured rat mesangial cells. Diabetes 36:240-243.
14. Kreisberg JI, Karnovsky MJ. 1983. Glomerular cells in culture. Kidney Int 23:439-447.
15. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Anal Biochem 162:156-159.
16. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275.
17. Halestrap AP, Prince NT. 1999. The proton-linked monocarboxylate transporter (MCT) family: Structure, function and regulation. Biochem J 343:281-299.
18. Garcia CK, Goldstein JL, Pathak RK, Anderson RGW, Brown MS. 1994. Molecular characterization of a membrane transporter for lactate, pyruvate, and other monocarboxylates: Implications for the Coli cycle. Cell 76:865-873.
19. Wilson MC, Jackson VN, Heddle C, Prince NT, Pilegaard H, Juel C, Bonen A, Montgomery I, Hutter OF, Halestrap AP. 1998. Lactic acid efflux from white skeletal muscle is catalyzed by the monocarboxylate transporter isoform MCT3. J Biol Chem 273:15920-15926.
20. Tamai I, Sai Y, Ono A, Kido Y, Yabuuchi H, Takanaga H, Satoh E, Ogihara T, Amano O, Izeki S, Tsuji A. 1999. Immunohistochemical and functional characterization of pH-dependent intestinal absorption of weak organic acids by the monocarboxylic acid transporter MCT1. J Pharm Pharmacol 51:1113-1121.
21. Juel C, Halestrap AP. 1999. Lactate transport in skeletal muscle-Role and regulation of the monocarboxylate transporter. J Physiol 517:633-642.
22. Fox JEM, Meredith D, Halestrap AP. 2000. Characterization of human monocarboxylate transporter 4 substantiates its role in lactic acid efflux from skeletal muscle. J Physiol 529:285-293.
23. Carter-Su C, Kimmich GA. 1979. Membrane potentials and sugar transport by ATP-depleted intestinal cells: Effect of anion gradients. Am J Physiol 237:C67-C74.
24. Clarke BL, Weigel PH. 1985. Recycling of the asialoglycoprotein receptor in the isolated rat hepatocytes. ATP depletion blocks receptor recycling but not a single round of endocytosis. J Biol Chem 260:128-133.
25. Versantvoort CHM, Broxterman HJ, Lankelma J, Feller N, Pinedo HM. 1994. Competitive inhibition by genistein and ATP-dependence of daunorubicin transport in intact MRP overexpressing human small lung cancer cells. Biochem Pharmacol 48:1129-1136.
26. Tamai I, Takanaga H, Maeda H, Sai Y, Ogihara T, Higashida H, Tsuji A. 1995. Participation of a proton-cotransporter, MCT1, in the intestinal transport of monocarboxylic acids. Biochem Biophys Res Commun 214:482-489.
27. Takanaga H, Tamai I, Inaba S-I, Sai Y, Higashida H, Yamamoto H, Tsuji A. 1995. cDNA cloning and functional characterization of rat intestinal monocarboxylate transporter. Biochem Biophys Res Commun 217:370-377.
28. Kido Y, Tamai I, Okamoto M, Suzuki F, Tsuji A. 2000. Functional clarification of MCT1-mediated transport of monocarboxylic acids at the bloodbrain barrier using in vitro cultured cells and in vivo BUI studies. Pharm Res 17:55-62.
29. Tsuji A, Saheki A, Tamai I, Terasaki T. 1993. Transport mechanism of 3-hydroxy-3-methylglutaryl co-enzyme A reductase inhibitors at the blood-brain barrier. J Pharmacol Exp Ther 267:1085-1090.
30. Pellerin L, Pellegri G, Bittar PG, Charnay Y, Bouras C, Martin J-L, Stella N, Magistretti PJ. 1998. Evidence supporting the existence of an activity-dependent astrocyte-neuron lactate shuttle. Dev Neurosci 20:291-299.
31. Prince NT, Jackson VN, Halestrap AP. 1998. Cloning and sequencing of four new mammalian monocarboxylate transporter (MCT) homologues confirms the existence of a transporter family with an ancient past. Biochem J 329:321-328.